Dong Baiqiang,Chen Ming.The application of stereotactic body radiotherapy in treatment of non-small cell lung cancer[J].Chinese Journal of Radiological Medicine and Protection,2016,36(10):732-735
The application of stereotactic body radiotherapy in treatment of non-small cell lung cancer
Received:July 12, 2016  
DOI:10.3760/cma.j.issn.0254-5098.2016.10.003
KeyWords:Stereotactic body radiotherapy  Non-small cell lung cancer  Side-effects
FundProject:
Author NameAffiliationE-mail
Dong Baiqiang Department of Radiotherapy, Zhejiang Cancer Hospital, Zhejiang Province Key Laboratory of Radiation Oncology, Hangzhou 310022, China  
Chen Ming Department of Radiotherapy, Zhejiang Cancer Hospital, Zhejiang Province Key Laboratory of Radiation Oncology, Hangzhou 310022, China chenming@zjcc.org.cn 
Hits: 2613
Download times: 2676
Abstract::
      Stereotactic body radiotherapy (SBRT) is a treatment of high dose radiation in a single or small number fractions to the target areas. Compared with conventional radiotherapy, SBRT has the features of higher dose and better precision. The application in lung cancer can be summarized as the following three points:① SBRT has established the status of standard treatment for early (T1-2N0M0) non-small cell lung cancer (NSCLC) patients who unable or unwilling to undergo surgery. ② The results of preliminary application of SBRT in the operable NSCLC are not inferior to surgery. ③ As for isolated metastases (1-3), the combination of systemic treatment and SBRT has been gradually accepted. This article makes a summary of this.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9064642  On-line:0

v
Scan QR Code
&et=93F632ED6E2662A6FCE07206EF7DDEE3B8E153D3829BAE7295F44DFA7D60A2CA3CD4B11CC565AB37A99DA69D36453215D44AA6590255D1C2507EDF69C17A7DD878312612C46CDE48C7F572AE8E4A48722129CE273EBD3B3518038C7A032DFCE6&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=9F915C6F01DE79C5&aid=05936A0FD5645515A2DB0872FD5E8210&vid=&iid=F3090AE9B60B7ED1&sid=20D29EF591CB2C94&eid=B60458D1AE87BCD1&fileno=20161003&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="9F915C6F01DE79C5"; var my_aid="05936A0FD5645515A2DB0872FD5E8210";